Advertisement
Research Article Free access | 10.1172/JCI106014
1Clinical Endocrinology Branch, National Heart Institute and the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Find articles by George, J. in: JCI | PubMed | Google Scholar
1Clinical Endocrinology Branch, National Heart Institute and the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Wolff, S. in: JCI | PubMed | Google Scholar
1Clinical Endocrinology Branch, National Heart Institute and the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Diller, E. in: JCI | PubMed | Google Scholar
1Clinical Endocrinology Branch, National Heart Institute and the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014
Find articles by Bartter, F. in: JCI | PubMed | Google Scholar
Published March 1, 1969 - More info
A sensitive method for determination of plasma unconjugated etiocholanolone by double-isotope-derivative dilution has been described. The mean values for normal subjects was 0.038±0.003 (SEM) μg/100 ml.
40 patients, 20 with familial Mediterranean fever and 20 with other diseases characterized by recurrent fever were studied. The over-all mean concentration of plasma unconjugated etiocholanolone for the patients (febrile or afebrile) was 0.101 ±0.012 μg/100 ml, significantly above that of normals. Mean plasma values for the patients while they were febrile did not differ from the mean values when they were afebrile. It is suggested that the concentration of plasma unconjugated etiocholanolone is not related to fever in these patients.